Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
Background: Testosterone replacement therapy (TRT) is one of the main lines of treatment for men with hypogonadism. This study sought to evaluate the influence of TRT in men with late-onset hypogonadism (LOH), regarding fatigue, coronary artery disease (CAD), carotid intima-media thickness (CIMT) an...
Saved in:
Main Authors: | Maurício de Almeida Ferreira (Author), José Alexandre Mendonça (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transdermal testosterone replacement therapy in men
by: Ullah MI, et al.
Published: (2014) -
Remission of type 2 diabetes in a young, hypogonadal man under long-term testosterone therapy: A case report
by: George Mskhalaya, et al.
Published: (2020) -
Effects of testosterone and vitamin D on fall risk in pre-frail hypogonadal men: a factorial design RCT
by: Heike A. Bischoff-Ferrari, et al.
Published: (2024) -
Testosterone replacement therapy and cardiovascular events
by: Alp Burak Çatakoğlu, et al.
Published: (2017) -
Hormone Replacement Therapy in a Patient with Hypogonadism and Coexisting Medical Conditions
by: Özlem Dural, et al.
Published: (2020)